• Halazepam, Urine
  • Inducible Costimulator (ICOS) Gene mutation analysis
  • MyoMarker 3 Plus Profile for Idiopathic Inflammatory Myopathies
  • Isoniazid, Serum
  • COL1A1/COL1A2 Genes Variations Analysis
  • Semen Analysis
  • SARS-CoV-2 (Coronavirus), Antigen Test
  • Phosphorylated Tau 181 (pTau-181), Plasma
  • Mismatch Repair (MMR) Protein, Immunohistochemistry
  • Fungal Pathogens (Dermatophyte, Non-dermatophyte Molds and Yeast), Molecular
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Diseases (2)
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.
Loading...